Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
(Total Views: 400)
Posted On: 01/11/2024 8:19:55 PM
Post# of 30067
Avatar
Posted By: freegriff
Dr. Urano has been invited to speak about gene and regenerative therapies for Wolfram syndrome at the Rare Disease Day Event 2024 at the National Institutes of Health. MANF is about to get its national stage Feb 29th 2:20pm Eastern.

https://ncats.nih.gov/news-events/events/rdd

2:20 p.m. Rare Story #6: Wolfram Syndrome: Diagnosis, Clinical Protocols, and Advances in Gene Editing, Regenerative, and Molecular Targeted Therapies Fumihiko Urano, M.D., Ph.D., FACMG, Samuel E. Schechter Professor of Medicine, Director of Wolfram Syndrome and Related Disorders Clinic, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine in St. Louis













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site